Company / EPS (Diluted)
Boston Scientific EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$1.94
FY2025
5-year range
$0.45 / $3.33
FY2021-FY2025
Trend
+55.2%
vs FY2024
Sector context
#55 of 159
Health Care
What the data says
At $1.94, Boston Scientific's eps (diluted) ranks #55 of 159 in the Health Care sector. EPS (Diluted) has increased for 3 consecutive years, from $0.45 in FY2022 to $1.94 in FY2025.
Based on SEC 10-K filings.
1.94 in FY2025 with a 5-year CAGR of +10.3%.
Improved from $0.69 to $1.94 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +62.8%
- 5-Year CAGR
- +10.3%
- 10-Year CAGR
- -
Sector benchmark
#55 of 159 in Health CareTop 35% of 159This company $1.94 Sector average $1.56
▼
+24.6% above sector average
Key checks
Key Insights
- Boston Scientific's eps (diluted) has grown for 3 consecutive years.
- In FY2025, eps (diluted) increased 55.2% year-over-year.
- Ranks #55 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.94 | +55.2% |
| FY2024 | $1.25 | +81.2% |
| FY2023 | $0.69 | +53.3% |
| FY2022 | $0.45 | -86.5% |
| FY2021 | $3.33 | +179.8% |
| FY2020 | $1.19 | -64.3% |
| FY2019 | $3.33 | +179.8% |
| FY2018 | $1.19 | +1387.5% |
| FY2017 | $0.08 | +188.9% |
| FY2016 | -$0.09 | +0.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026